E-GEOD-46992 - Genome-wide map of p53 binding sites by ChIP-seq in human lymphoblastoid cell lines treated with nutlin-3

Status
Released on 23 October 2013, last updated on 25 November 2013
Organism
Homo sapiens
Samples (2)
Protocols (4)
Description
We have used chromatin immune-precipitation with parallel sequencing (ChIP-Seq) technology to identify genome-wide p53 binding in human lymphoblastoid cell lines treated with a MDM2 inhibitor nutlin-3 ChIP-Seq analysis of p53 binding sites in human lymphoblastoid cells treated with nutlin-3 or vehicle
Experiment type
ChIP-seq 
Contacts
Dan Su, Douglas A Bell, Michelle R Campbell, Xuting Wang
Citation
A Polymorphic p53 Response Element in KIT Ligand Influences Cancer Risk and Has Undergone Natural Selection. Zeron-Medina J, Wang X, Repapi E, Campbell MR, Su D, Castro-Giner F, Davies B, Peterse EF, Sacilotto N, Walker GJ, Terzian T, Tomlinson IP, Box NF, Meinshausen N, De Val S, Bell DA, Bond GL. , Europe PMC 24120139
MINSEQE
Exp. designProtocolsFactorsProcessedSeq. reads
Files
Investigation descriptionE-GEOD-46992.idf.txt
Sample and data relationshipE-GEOD-46992.sdrf.txt
Links